Previous Meetings

GBCC 2016

Global Breast Cancer Conference 2016

07:30-08:10
Breakfast Symposium 2
Venue: Halla Hall
  • Prophylaxis of Febrile Neutropenia: Experiences with Adjuvant TAC
    Jihyoun Lee (Soonchunhyang Univ. Hospital Seoul, Korea)
08:00-09:30
Practicing Breast Surgeons Session
Ultimate Tips of VABB Device
Venue: Weolla Room
  • Comparison of the Pros & Cons of VABB Devices, Bexcore, Mammotome and Encore
    Soo Jin Kim (Chungdam Seoul Breast Clinic, Korea)
  • Prevention and Management of VABB Complication
    Dong Seok Lee (Bunhongbit Hospital, Korea)
  • Knowhow to Perform VABB for Technically Difficult Accessible Breast Masses Subareolar Mass. Breast Mass Nearby Skin. Larger than 5cm Size Breast Mass
    Jeong Kyeung Kim (Maria Breast Clinic, Korea)
  • VABB Can Be an Excellent Tool for Biopsy of Microcalcifications: Micropure Guided VABB, J Wire Guided VABB
    Kyung Ho Cha (Mamma Breast Clinic, Korea)
  • Management of Premalignant Lesions after VABB. ADH, ALH, LCIS, Flat Epithelial Atypia, Columnar Cell Change, Papillary Lesions, Phyllodes Tumor
    Tae Ik Eom (HiU Breast Clinic, Korea)
  • Legal Consulting for Running Breast Clinic: Medical Insurance Issues with Law Firm
    Junseok Lee (Sunwoo LLC, Korea)
08:30-09:30
Plenary Lecture 5
Venue: Halla Hall
  • Two Decades at the NSABP - B27 to 57, and Unsolved Mysteries
    Soonmyung Paik (Yonsei Univ. College of Medicine, Korea)
09:40-10:50
Symposium 8
Enhancing Endocrine Therapy for ER-positive Breast Cancer: Co-targeting Signaling Pathways
Venue: Halla Hall
  • Sensitization of Breast Cancer Cells to Chemotherapeutic Drugs by Metabolic Regulation
    In-Chul Park (Korea Institute of Radiological and Medical Sciences, Korea)
  • Cross-talk between Adiponectin and IGF-IR in Breast Cancer
    Young-Jin Suh (The Catholic Univ. of Korea, St. Vincent's Hospital, Korea)
  • Bidirectional Crosstalk between the ER and HER2 Signaling Pathways: From Bench to Bedside
    Joohyuk Sohn (Yonsei Cancer Center, Korea)
Education Session 2
Immune-oncologic Approaches as Innovative Therapeutic Strategy for Refractory Breast Cancer
Venue: Lotus Hall
  • Value of Immune Infiltration to Predict Therapeutic Outcomes
    Hee Jin Lee (ASAN Medical Center, Univ. of Ulsan College of Medicine, Korea)
  • Immune Targeting in Breast Cancer
    Leisha A Emens (Johns Hopkins Univ.-School of Medicine, U.S.A)
  • Combination Immunotherapy Approaches: Chemotherapy, Radiation Therapy, and Dual Checkpoint Therapy
    David Page (Providence Portland Cancer Center, Earle A. Chiles Research Institute, U.S.A.)
Oral Presentation 2
Venue: Weolla Room
  • INVESTIGATION OF CYTOTOXIC AND APOPTOTIC EFFECTS OF URTICA DIOICA AGGLUTININ ON MCF-7 AND L929 CELL LINES
    Tutku Ozarpaci (Fatih Univ., Turkey)
  • SCREENING BY ABBREVIATED BREAST MAGNETIC RESONANCE IMAGING (MRI) IN WOMEN WITH A HISTORY OF BREAST CANCER OPERATION
    Bo Hwa Choi (Konkuk Univ. Medical Center, Korea)
  • ANALYSIS OF INTERVAL BREAST CANCER WITH A SINGLE CENTER DATASET
    Jae Yang Lim (Dr. Lim’s Breast Clinic, Korea)
  • ESTIMATING THE COST OF WORK LOSS OF CANCER SURVIVORS IN JAPAN
    Hideko Yamauchi (St. Luke's International Hospital, Japan)
  • THE RISK FACTORS OF PREGNANCY-ASSOCIATED BREAST CANCER IN KOREAN WOMEN
    Yun Gyoung Kim (Korea Cancer Center Hospital, Korea)
  • EFFICACY OF DOCETAXEL , TRASTUZUMAB AND PERTUZUMAB COMBINATION REGIMEN FOR HER2-POSITIVE METASTATIC BREAST CANCER
    Tsutomu Takashima (Osaka City Univ. Graduate School of Medicine, Japan)
  • INFLUENCE OF BODY MASS INDEX AT DIAGNOSIS IN RELATION TO HORMONE RECEPTOR, MENOPAUSAL AND NODAL STATUS ON BREAST CANCER PROGNOSIS
    Il Yong Chung (ASAN Medical Center, Korea)
  • THE DISTRIBUTION OF PROBANDS AND BRCA CARRIERS FROM 4 ASIAN BREAST CANCER STUDIES (SINGAPORE, CHINA AND KOREA)
    Heewon Kim (Seoul National Univ. College of Medicine, Korea)
10:50-12:00
Symposium 9
New Area for Anti-cancer Drug Development in Breast Cancer
Venue: Halla Hall
  • Combination Strategy in Cancer Immuno-oncology Drug Development
    Soohyeon Lee (Pfizer Korea, Korea)
  • The Tumor Microenvironment: A Driving Force for Breast Cancer Progression
    Hyeong-Gon Moon (Seoul National Univ. College of Medicine, Korea)
  • Targeting the Androgen Receptor in Breast Cancer
    Elgene Lim (Garvan Institute of Medical Research, Australia)
Education Session 3
New Paradigm for Overcoming Endocrine Resistance
Venue: Lotus Hall
  • New Paradigm for Overcoming Endocrine Resistance - Targeting CDK 4/6
    Jee Hyun Kim (Seoul National Univ. Bundang Hospital, Korea)
  • PI3K/mTORor Pathway
    Woochul Noh (Korea Cancer Center Hospital, Korea)
  • ESR1 Mutations-A Mechanism for Acquired Endocrine Resistance in Breast Cancer
    Kyong Hwa Park (Korea Univ. Anam Hospital, Korea)
Oral Presentation 3
Venue: Weolla Room
  • SYNTHESIZATION, CHARACTERIZATION OF FOLIC ACID AND QUERCETIN FUNCTIONALIZED MAGNETIC NANOPARTICLES RESEARCH ON BREAST CANCER CELL LINE FOR HYPERTHERMIA AND TARGETED DRUG DELIVERY APPLICATIONS
    Zeynep Ulker Akal (Fatih Univ., Turkey)
  • BREAST CANCER RISK ASSOCIATIONS WITH DIGITAL MAMMOGRAPHIC DENSITY BY MAMMOGRAPHY DENSITY THRESHOLDS AND MAMMOGRAPHY SYSTEM
    Kevin Nguyen (The Univ. of Melbourne, Australia)
  • TARGETING A NOVEL CHEMORESISTANCE GENE, ZBTB2, TO OVERCOME CISPLATIN-RESISTANCE IN TRIPLE-NEGATIVE BREAST CANCER
    Vivian Shin (The Univ. of Hong Kong, Hong Kong)
  • THE ROLE OF PREOPERATIVE BREAST MAGNETIC RESONANCE (MR) IMAGING FOR SURGICAL DECISION IN PATIENTS WITH TRIPLE-NEGATIVE BREAST CANCER
    Jeeyeon Lee (Kyungpook National Univ. Hospital, Korea)
  • CHANGES OF ABDOMINAL FAT DISTRIBUTION AFTER ENDOCRINE THERAPY IN BREAST CANCER PATIENTS
    Jong Oh Lee (Hanyang Univ. College of Medicine, Korea)
  • DEVELOPMENT OF SECOND PRIMARY CANCERS IN KOREAN BREAST CANCER SURVIVORS
    Hong Kyu Jung (Soonchunhyang Univ. Hospital Seoul, Korea)
  • THE PRECISE QUANTIFICATION OF PROGESTERONE RECEPTOR COULD BE AN ALTERNATIVE TO THE RECURRENT SCORE IN HORMONE RECEPTOR-POSITIVE EARLY BREAST CANCER
    Moo Hyun Lee (National Cancer Center, Korea)
  • SIX-YEAR FOLLOW UP OF BREAST-CONSERVING SURGERY USING SUPINE MAGNETIC RESONANCE IMAGING IN BREAST CANCER PATIENTS RECEIVING PRIMARY SYSTEMIC THERAPY
    Takafumi Sangai (Chiba Univ., Japan)
Back to Previous Meetings